Skip to main content

Table 4 Characteristics of patients in the the re-audit period

From: Anticancer therapy within the last 30 days of life: results of an audit and re-audit cycle from an Australian regional cancer centre

 

All Patients

Treatment within last 30 days

No treatment within last 30 days

 

Number

Percent

Number

Percent

Number

Percent

 

75

 

19

25%

56

75%

Sex

 Male

40

53%

10

53%

30

54%

 Female

35

47%

9

47%

26

46%

Discipline

 Oncology

65

87%

19

29%

46

71%

 Hematology

10

13%

0

0%

10

100%

 Average age (years)

70.1

 

66.9

 

71.1

 

Performance status

 ECOG 0 or 1

30

40%

4

21%

26

46%

 ECOG 2

29

39%

7

37%

22

39%

 ECOG 3 or 4

16

21%

8

42%

8

14%

Line of treatment

 Never treated

6

8%

  

6

11%

 First line

25

33%

3

16%

22

39%

 Second line

25

33%

10

53%

15

27%

 Third line or greater

19

25%

6

32%

13

23%